Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGER | Q15109 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
| ▸ | VDR | P11473 | 1/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | GBA1 | P04062 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29224493 | 0.86 | AGER (0.46) | AGERGAACA2CA1CA12 | |
| SCHEMBL872063 | 0.86 | AGER (0.48) | AGERGAACA2CA1CA12 | |
| SCHEMBL17350536 | 0.85 | AGER (0.42) | AGERGAACA2CA1CA12 | |
| SCHEMBL5557903 | 0.85 | GAA (0.52) | AGERGAACA2CA1CA12 | |
| SCHEMBL2342945 | 0.85 | GAA (0.52) | AGERGAACA2CA1CA12 | |
| SCHEMBL143705 | 0.83 | GAA (0.50) | AGERGAACA2CA1CA12 | |
| SCHEMBL890642 | 0.83 | GAA (0.50) | AGERGAACA2CA1CA12 | |
| SCHEMBL1414705 | 0.82 | AGER (0.46) | AGERGAACA2CA1CA12 | |
| SCHEMBL4671544 | 0.82 | GBA1 (0.42) | AGERGAACA2CA1CA12 | |
| SCHEMBL9711306 | 0.82 | AGER (0.42) | AGERGAACA2CA1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117865858-A | Novel PET imaging agent targeting cannabinoid type 2 receptor, preparation method and application thereof | 浙江大学 | 2024-04-12 | — | — | CN | claimed |
| CN-117199523-A | Electrolyte, secondary battery and electric equipment | 欣旺达动力科技股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| US-11242314-B2 | Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride | WASHINGTON UNIVERSITY (US) | 2022-02-08 | — | — | US | claimed |
| CN-111233834-B | FAK-targeting compound and markers thereof, and preparation methods and applications of FAK-targeting compound and markers | 北京师范大学 | 2021-08-31 | — | — | CN | claimed |
| US-20170197912-A1 | SYNTHESIZING PET TRACERS USING [F-18]SULFONYL FLUORIDE AS A SOURCE OF [F-18]FLUORIDE | WASHINGTON UNIVERSITY (US) | 2017-07-13 | — | — | US | claimed |
| US-20150367005-A1 | METHOD OF SYNTHESIZING FLUORINE-18 LABELED RADIOPHARMACEUTICALS IN ETHANOL AND WATER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-12-24 | — | — | US | claimed |
| WO-2008132211-A1 | AMINO-QUINAZOLINONE DERIVATIVES FOR USE AS RADIOTRACERS AND IMAGING AGENTS | NOVARTIS AG (CH) | 2008-11-06 | — | — | WO | claimed |
| EP-4680596-A1 | FLUORINATED MU-OPIOID RECEPTOR AGONISTS | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024196438-A9 | FLUORINATED MU-OPIOID RECEPTOR AGONISTS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-11-13 | — | — | WO | disclosed |
| US-20250339566-A1 | INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN | UNIV ANTWERPEN (BE) | 2025-11-06 | — | — | US | disclosed |
| US-12324845-B2 | Ligands for imaging cardiac innervation | LANTHEUS MEDICAL IMAGING, INC. (US) | 2025-06-10 | — | — | US | disclosed |
| US-20250161500-A1 | LIGANDS FOR IMAGING CARDIAC INNERVATION | LANTHEUS MEDICAL IMAGING, INC. (US) | 2025-05-22 | — | — | US | disclosed |
| WO-2025085387-A1 | SUBSTITUTED-ALKENYL-INDAZOLES FOR IMAGING AGGREGATED TAU IN TAUOPATHIES | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2025-04-24 | — | — | WO | disclosed |
| US-20030158460-A1 | Radiolabeled solid surfaces and process for making them | BAR-ILAN UNIVERSITY (IL) | 2003-08-21 | — | — | US | disclosed |
| EP-1096934-A1 | OXAZOLIDINONES TO TREAT EYE INFECTIONS | PHARMACIA & UPJOHN COMPANY (US) | 2001-05-09 | — | — | EP | disclosed |
| EP-1083900-A2 | TOPICAL ADMINISTRATION OF OXAZOLIDINONES FOR TRANSDERMAL DELIVERY | PHARMACIA & UPJOHN COMPANY (US) | 2001-03-21 | — | — | EP | disclosed |
| WO-2000003710-A1 | OXAZOLIDINONES TO TREAT EYE INFECTIONS | PHARMACIA & UPJOHN COMPANY (US) | 2000-01-27 | — | — | WO | disclosed |
| WO-1999062504-A2 | TOPICAL ADMINISTRATION OF OXAZOLIDINONES FOR TRANSDERMAL DELIVERY | PHARMACIA & UPJOHN COMPANY (US) | 1999-12-09 | — | — | WO | disclosed |
| EP-0882041-A1 | PIPERAZINONEPHENYLOXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | AstraZeneca AB (SE) | 1998-12-09 | — | — | EP | disclosed |
| WO-1997027188-A1 | PIPERAZINONEPHENYLOXAZOLIDINONE DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS | ZENECA LIMITED (GB) | 1997-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170197912-A1 | SYNTHESIZING PET TRACERS USING [F-18]SULFONYL FLUORIDE AS A SOURCE OF [F-18]FLUORIDE | STX18, GPR119, SLC5A1 | AGER 532/4885GAA 268/4885CA2 818/4885 |
| US-11242314-B2 | Synthesizing pet tracers using [F-18]sulfonyl fluoride as a source of [F-18]fluoride | STX18, GPR119, SLC5A1 | AGER 532/4885GAA 268/4885CA2 818/4885 |
| US-20150367005-A1 | METHOD OF SYNTHESIZING FLUORINE-18 LABELED RADIOPHARMACEUTICALS IN ETHANOL AND WATER | TMEM14C, ADH1A, SELENOI | AGER 3342/4885GAA 1392/4885CA2 2348/4885 |
| US-20250339566-A1 | INHIBITORS OF FIBROBLAST ACTIVATION PROTEIN | FIBP, FGF1, FGFR1 | AGER 1576/4885GAA 766/4885CA2 362/4885 |
| US-20250161500-A1 | LIGANDS FOR IMAGING CARDIAC INNERVATION | TNNT2, PNMT, TNNC1 | AGER 703/4885GAA 2929/4885CA2 3921/4885 |
| US-12324845-B2 | Ligands for imaging cardiac innervation | CHRNB4, RXFP4, RXFP3 | AGER 1382/4885GAA 4426/4885CA2 1423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.